首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Comment on 'Hypericin uptake: a prognostic marker for survival in high-grade glioma'.
【24h】

Comment on 'Hypericin uptake: a prognostic marker for survival in high-grade glioma'.

机译:评论“摄取Hypericin:高级神经胶质瘤生存的预后标志”。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

I read the article entitled "Hypericin uptake: A prognostic marker for survival in high-grade glioma" by R. Ritz et al. published in the Journal of Clinical Neuroscience in 2008.1 They investigated the uptake of the fluorescent photosensitizer, hypericin, into an ex vivo cell line established from a clinical sample of human glioma. They reported a positive correlation between the fluorescent intensity of the glioma cells and the prognosis of the patients from whom the glioma specimens had been surgically removed.
机译:我读了R. Ritz等人的标题为“高丝菌素摄取:高级神经胶质瘤生存的预后标志物”的文章。他们于2008年发表在《临床神经科学杂志》上。1他们研究了从人类神经胶质瘤临床样本建立的离体细胞系对荧光光敏剂金丝桃素的摄取情况。他们报告了神经胶质瘤细胞的荧光强度与手术切除了神经胶质瘤标本的患者的预后之间呈正相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号